This event has ended. Visit the official site or create your own event on Sched.


Ti Cai

EMD Serono
Director, Global Clinical Biomarkers and Companion Diagnostics
Ti Cai joined EMD Serono in March 2015 as Director, Clinical Biomarkers and Companion Diagnostics. He is currently leading clinical biomarker development for avelumab (anti-PD-L1 antibody) program. Prior to EMD Serno, Ti worked at Celgene, Sanofi and Amgen where he led biomarker research for multiple projects. Ti Cai completed his undergraduate study at Fudan Univeristy in China, obtained his PhD degree at State University of New York and performed post-doctoral training at Stanford University.